Universe Pharmaceuticals ...

AI Score

XX

Unlock

3.34
0.46 (15.97%)
At close: Apr 04, 2025, 3:59 PM
3.50
4.81%
After-hours: Apr 04, 2025, 05:57 PM EDT

Universe Pharmaceuticals INC Statistics

Share Statistics

Universe Pharmaceuticals INC has 216.53K shares outstanding. The number of shares has increased by -0.24% in one year.

Shares Outstanding 216.53K
Shares Change (YoY) -0.24%
Shares Change (QoQ) -0.05%
Owned by Institutions (%) 0.47%
Shares Floating 213.06K
Failed to Deliver (FTD) Shares -
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 159.9K, so 7.6% of the outstanding shares have been sold short.

Short Interest 159.9K
Short % of Shares Out 7.6%
Short % of Float 8.14%
Short Ratio (days to cover) 0.11

Valuation Ratios

The PE ratio is -335.26 and the forward PE ratio is null. Universe Pharmaceuticals INC's PEG ratio is 11.38.

PE Ratio -335.26
Forward PE n/a
PS Ratio 63.95
Forward PS null
PB Ratio 52.27
P/FCF Ratio 1920.46
PEG Ratio 11.38
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Universe Pharmaceuticals INC.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.14.

Current Ratio 2.68
Quick Ratio 2.43
Debt / Equity 0.14
Debt / EBITDA -1.71
Debt / FCF 5.1
Interest Coverage -22.49

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $143.59K
Profits Per Employee $-27.39K
Employee Count 225
Asset Turnover 0.61
Inventory Turnover 6.58

Taxes

Income Tax 2.31M
Effective Tax Rate -60.1%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 1.57, so Universe Pharmaceuticals INC's price volatility has been higher than the market average.

Beta 1.57
52-Week Price Change null%
50-Day Moving Average 7.21
200-Day Moving Average 644.4
Relative Strength Index (RSI) 36.35
Average Volume (20 Days) -

Income Statement

In the last 12 months, Universe Pharmaceuticals INC had revenue of 32.31M and earned -6.16M in profits. Earnings per share was -1.7.

Revenue 32.31M
Gross Profit 10.32M
Operating Income -3.53M
Net Income -6.16M
EBITDA -3.22M
EBIT -3.69M
Earnings Per Share (EPS) -1.7
Full Income Statement

Balance Sheet

The company has 5.29M in cash and 5.48M in debt, giving a net cash position of -197.21K.

Cash & Cash Equivalents 5.29M
Total Debt 5.48M
Net Cash -197.21K
Retained Earnings 10.16M
Total Assets 49.43M
Working Capital 12.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.12M and capital expenditures -44.17K, giving a free cash flow of 1.08M.

Operating Cash Flow 1.12M
Capital Expenditures -44.17K
Free Cash Flow 1.08M
FCF Per Share 0.3
Full Cash Flow Statement

Margins

Gross margin is 31.93%, with operating and profit margins of -10.92% and -19.08%.

Gross Margin 31.93%
Operating Margin -10.92%
Pretax Margin -11.91%
Profit Margin -19.08%
EBITDA Margin -9.95%
EBIT Margin -10.92%
FCF Margin 3.33%

Dividends & Yields

UPC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for UPC.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Mar 24, 2025. It was a backward split with a ratio of 1:40.

Last Split Date Mar 24, 2025
Split Type backward
Split Ratio 1:40

Scores

Altman Z-Score -0.34
Piotroski F-Score 1